Bersuker and colleagues used CRISPR/Cas9 screening methods to screen for apoptosis in cells treated with RSL3 and a tumor single-guide RNA (sgRNA) library and found that FSP1 can inhibit ferroptosis through a GPX4-independent mechanism (61). This evidence concerns the gene GPX4 and neoplasm.